HB 51-LABELING OF PRESCRIBED DRUGS    CHAIR FRED DYSON announced HB 51 to be up for discussion. REPRESENTATIVE PAUL SEATON, sponsor, explained that HB 51 requires prescription labels to contain the generic name as well as any brand name. The purpose for the dual labeling is the health and safety of Alaskans. Ways of treating illnesses have changed drastically, especially chronic illnesses. Many more pills are available and typically a person takes all of their bottles and sets each prescription out for the week. If a person orders a prescription and gets it with a brand name on it, it will only have that name on it. If they get a refill, they might get only the generic name. So, a person goes to fill his pill containers and doesn't know precisely what the prescriptions are and ends up double dosing. This has been a very significant problem, especially for senior citizens. He said the University of Chicago and the FDA have done studies and found that 15 percent of all the drug problems are caused by drug overdoses, because people were unable to distinguish the names. This is one of the 15 recommendations by the FDA. AARP, the Alaska Association of Health Underwriters, the Alaskan State Medical Association, Aetna Insurance, and a number of senior citizen homes support this. No one opposes it. CHAIR DYSON said he assumed that the pharmaceutical industry had been informed and that they support it. REPRESENTATIVE SEATON replied that is correct. MR. FRED LAU, Director, Homer Senior Citizens, Inc., an organization that runs programs for seniors 55 and older for nutrition, transportation, adult day care, assisted living, respite and independent living, affirmed that a large number of seniors are taking from 5 to 15 medications. They support this bill for the reasons Representative Seaton explained. SENATOR GUESS moved HB 51 and the attached zero fiscal note out of committee with individual recommendations. There were no objections and it was so ordered.